Neil Gallagher
First SEC filing: April 2, 2024 · Latest: April 2, 2024
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 24, 2026 | FHTX | A | 28,000 | $4.08 | $114,240 | 28,000 Direct | · | Acquired | -50.5% (price as of 2026-10-02) |
| May 1, 2025 | FHTX | A | 50,000 | $4.16 | $208,000 | 50,000 Direct | · | Acquired | -51.4% (price as of 2026-10-02) |
| Feb. 10, 2025 | SNDX | S | 4,618 | $15.50 | $71,579 | 85,095 Direct | -5.15% | Disposed | 13.5% (price as of 2026-10-02) |
| Feb. 5, 2025 | SNDX | A | 110,500 | $14.65 | $1,618,825 | 110,500 Direct | · | Acquired | 20.1% (price as of 2026-10-02) |
| Feb. 5, 2025 | SNDX | A | 23,400 | · | · | 89,713 Direct | +35.29% | Acquired | (price as of 2026-10-02) |
| Feb. 5, 2025 | SNDX | A | 18,500 | · | · | 66,313 Direct | +38.69% | Acquired | (price as of 2026-10-02) |
| Dec. 10, 2024 | ZYME | A | 31,000 | · | · | 31,000 Direct | · | Acquired | (price as of 2026-10-02) |
| April 2, 2024 | ZYME | A | 74,000 | · | · | 74,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 7, 2024 | SNDX | A | 34,688 | · | · | 34,688 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 7, 2024 | SNDX | A | 13,125 | · | · | 47,813 Direct | +37.84% | Acquired | (price as of 2026-10-02) |
| Feb. 7, 2024 | SNDX | A | 69,375 | $22.28 | $1,545,675 | 69,375 Direct | · | Acquired | -21.0% (price as of 2026-10-02) |
| April 10, 2023 | SNDX | A | 250,000 | $19.35 | $4,837,500 | 250,000 Direct | · | Acquired | -9.0% (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 24, 2026 | FHTX | Stock Options (Right to buy) | Common Stock | $4.08 | June 23, 2036 | 28,000 | Acquired |
| May 1, 2025 | FHTX | Stock Options (Right to buy) | Common Stock | $4.16 | April 30, 2035 | 50,000 | Acquired |
| Feb. 5, 2025 | SNDX | Stock Options (Right to buy) | Common Stock | $14.65 | Feb. 5, 2035 | 110,500 | Acquired |
| Dec. 10, 2024 | ZYME | Stock Option (Right to Buy) | Common Stock | $13.06 | Dec. 9, 2034 | 31,000 | Acquired |
| April 2, 2024 | ZYME | Stock Option (Right to Buy) | Common Stock | $9.23 | April 1, 2034 | 74,000 | Acquired |
| Feb. 7, 2024 | SNDX | Stock Options (Right to buy) | Common Stock | $22.28 | Feb. 7, 2034 | 69,375 | Acquired |
| April 10, 2023 | SNDX | Stock Options (Right to buy) | Common Stock | $19.35 | April 10, 2033 | 250,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 2 holdings
Securities held when first becoming an insider, per SEC Form 3.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2024 | $546,000 | · | $1,065,274 | $1,037,205 | $269,588 | · | $10,000 | $2,928,067 |
| 2023 | $386,458 | · | · | $3,318,187 | $182,229 | · | $5,300 | $3,892,174 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.